INTRANASAL MICROEMULGEL AS SURROGATE CARRIER TO ENHANCE LOW ORAL BIOAVAILABILITY OF SULPIRIDE

Faculty Pharmacy Year: 2016
Type of Publication: ZU Hosted Pages: 188-197
Authors:
Abdullah Mohammed Abdullah Ayub
Journal: International Journal of Pharmacy and Pharmaceutical Sciences Innovare Academic Sciences Pvt Ltd Volume: 10
Keywords : INTRANASAL MICROEMULGEL , SURROGATE CARRIER , ENHANCE , ORAL BIOAVAILABILITY    
Abstract:
Objective: The purpose of this study is to evaluate microemulsion based gel (MBG) of sulpiride "a poorly water soluble antipsychotic with low oral bioavailability." Methods: Gelling polymers such as sodium carboxymethylcellulose (CMC-Na),
    
     
 
       

Author Related Publications

  • Abdullah Mohammed Abdullah Ayub, "INTRANASAL MICROEMULGEL AS SURROGATE CARRIER TO ENHANCE LOW ORAL BIOAVAILABILITY OF SULPIRIDE", international journal of pharmacy and pharmacutical science, 2016 More
  • Abdullah Mohammed Abdullah Ayub, "Sulpiride microemulsions as antipsychotic nasal drug delivery systems: In-vitro and pharmacodynamic study", Journal of Drug Delivery Science and Technology, 2016 More
  • Abdullah Mohammed Abdullah Ayub, "Sulpiride microemulsions as antipsychotic nasal drug delivery systems: In-vitro and pharmacodynamic study", elsevier, 2016 More

Department Related Publications

  • Fakhreldeen Soliman Ghazy Shehata, "Solid dispersion approach for optimized bioavailability of sulpiride", Lat.Am.j.Pharm, 2013 More
  • Nagia] Ahmed Alameen Elmgrab, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
  • Azza Ali Hassan Solyman, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
  • Eman Gomaa Ahmed alsayed, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
Tweet